Basaglar diabetes drug is a long-acting, man-made human insulin therapy recently approved by the FDA. It is made by Eli Lilly in partnership with Boehringer Ingelheim as a cheaper version of Sanofi's Lantus drug.
Basaglar diabetes drug is a long-acting, man-made human insulin therapy recently approved by the FDA. It is made by Eli Lilly in partnership with Boehringer Ingelheim as a cheaper version of Sanofi's Lantus drug.